Protopapas Anna - Insider Transactions
Insider Type
individual
Companies
2
Average
110,843
Total Txns
6
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2023 | 0 | 1 | -1 | 0.00 | 378,350.00 | -378,350.00 |
| 2024 | 0 | 2 | -2 | 0.00 | 159,342.58 | -159,342.58 |
| 2025 | 0 | 3 | -3 | 0.00 | 16,522.23 | -16,522.23 |
| Total: | 0 | 6 | 6 | 0.00 | 554,214.81 | -554,214.81 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Mersana Therapeutics, Inc. Common Stock US59045L1061 |
0.58 USD |
8,637 Sold |
5,009 USD |
15/01/2025 | 16/01/2025 |
| Mersana Therapeutics, Inc. Common Stock US59045L1061 |
0.63 USD |
6,191 Sold |
3,900 USD |
14/01/2025 | 15/01/2025 |
| Mersana Therapeutics, Inc. Common Stock US59045L1061 |
0.66 USD |
11,534 Sold |
7,612 USD |
13/01/2025 | 14/01/2025 |
| Mersana Therapeutics, Inc. Common Stock US59045L1061 |
2.71 USD |
29,399 Sold |
79,671 USD |
13/01/2024 | 16/01/2024 |
| Mersana Therapeutics, Inc. Common Stock US59045L1061 |
2.71 USD |
29,399 Sold |
79,671 USD |
13/01/2024 | 16/01/2024 |
| Nuvalent, Inc. Class A Common Stock US6707031075 |
75.67 USD |
5,000 Sold |
378,350 USD |
18/12/2023 | 18/12/2023 |